Medline (MDLN) vs Solventum (SOLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Medline is the larger company by market cap ($48.75 billion vs $14.36 billion), about 3.4 times the size. On valuation, Solventum trades at a lower forward P/E (11.2x vs 24.0x for Medline). Solventum converts more of its revenue into profit, with a net margin of 18.7% versus 4.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDLN | SOLV |
|---|---|---|
| Share price | $37.04 | $84.50 |
| Market cap | $48.75B | $14.36B |
| 1-day change | -2.11% | -1.52% |
| YTD return | -11.81% | +6.64% |
| 1-year return | — | +1.93% |
| P/E ratio (TTM) | 84.18 | 94.94 |
| Forward P/E | 23.98 | 11.20 |
| EPS (TTM) | $0.44 | $0.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $28.43B | $8.32B |
| Revenue growth (YoY) | — | +0.86% |
| Net income (latest FY) | $1.16B | $1.56B |
| Gross margin | 26.44% | 53.47% |
| Operating margin | 7.78% | 26.20% |
| Net margin | 4.08% | 18.69% |
| 52-week high | $50.88 | $94.16 |
| 52-week low | $31.37 | $62.38 |
| Distance from 52-week high | -27.20% | -10.26% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +23.52% | +16.43% |
| Average volume | 9.55M | 1.03M |
| Shares outstanding | 878.66M | 169.96M |
| Employees | 45,000 | 20,584 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Medline is about 3.4 times larger than Solventum by market value ($48.75B vs $14.36B).
- Solventum is more profitable, keeping 18.7 cents of every revenue dollar as net income versus 4.1 cents for Medline.
About Medline
MDLN stock →Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally.
Health Care · Medical/Dental Instruments · 45,000 employees
About Solventum
SOLV stock →Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.
Health Care · Medical/Dental Instruments · 20,584 employees
MDLN vs SOLV FAQ
Which is bigger, Medline or Solventum?
Medline (MDLN) is larger, with a market capitalization of $48.75B compared with $14.36B for Solventum (SOLV).
Which has the lower P/E ratio, MDLN or SOLV?
MDLN has the lower trailing P/E at 84.2, versus 94.9 for SOLV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Medline and Solventum in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.